Related Experiment Video
Updated: Mar 29, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Staphylococcus aureus Infections in Children With Congenital Heart Disease
J Chase McNeil1, John A Ligon2, Kristina G Hulten2
1Section of Infectious Diseases and jm140109@bcm.tmc.edu.
Insights
Staphylococcus aureus infections are common in children with congenital heart disease (CHD). Infective endocarditis (IE) is a frequent complication, with prolonged bacteremia and elevated CRP indicating higher risk.
Area of Science:
- Pediatric Infectious Diseases
- Cardiology
- Microbiology
Background:
- Congenital heart disease (CHD) is a primary risk factor for infective endocarditis (IE) in pediatric populations.
- Staphylococcus aureus is a leading cause of IE, yet specific risk factors for invasive S. aureus disease in children with CHD remain underexplored.
Purpose of the Study:
- To investigate the epidemiology of Staphylococcus aureus infections in children diagnosed with congenital heart disease.
- To identify risk factors and clinical outcomes associated with S. aureus infections in this vulnerable pediatric group.
Main Methods:
- Retrospective review of clinical and laboratory data from pediatric patients with CHD and S. aureus infection.
- Analysis of S. aureus isolates for the presence of the qacA/B gene, a marker for antiseptic tolerance.
- Statistical comparison of clinical variables using Fisher's exact test and Mann-Whitney U tests.
Main Results:
- 248 S. aureus infections occurred in 216 patients with CHD; 53.6% of isolates were methicillin-resistant.
- Surgical site infections (28.2%) and bacteremia (20.4%) were common, with IE complicating 29.5% of bacteremic episodes.
- Prolonged bacteremia, thrombocytopenia, and elevated C-reactive protein (CRP) were associated with IE. The qacA/B gene was detected in 16.9% of isolates, linked to bacteremia and longer hospital stays.
Conclusions:
- Staphylococcus aureus poses a significant threat, causing substantial morbidity in children with CHD.
- Infective endocarditis is a frequent complication of S. aureus bacteremia in this cohort. Prolonged bacteremia, thrombocytopenia, and CRP levels >10 mg/dL may aid in IE diagnosis.
- qacA/B-positive S. aureus isolates are associated with poorer clinical outcomes, highlighting potential targets for intervention.
Background:
Congenital heart disease (CHD) is the most common risk factor for infective endocarditis (IE) in children. Staphylococcus aureus is among the most common organisms to cause IE, yet there are little data describing the risk factors for invasive S aureus disease in children with CHD. We examined the epidemiology of S aureus infections in children with CHD.
Methods:
Patients with a history of CHD and S aureus infection were identified from a surveillance study of S aureus infections at Texas Children's Hospital. Clinical and laboratory data from medical records were reviewed. All isolates were screened for the presence of the antiseptic tolerance gene qacA/B. Dichotomous variables were compared with Fisher's exact test and continuous variables with Mann-Whitney U tests, and two-tailed P values of <.05 were considered significant.
Results:
Two hundred forty-eight S aureus infections developed in 216 patients with CHD. Methicillin resistance was seen in 53.6% of isolates. Surgical site infections accounted for 28.2% of cases and bacteremia accounted for 20.4% of cases. Bacteremia was associated with IE in 29.5% of the episodes. Infective endocarditis was more often associated with prolonged bacteremia, thrombocytopenia, and a higher C-reactive protein (CRP) compared with uncomplicated bacteremia. The qacA/B gene was found in 16.9% of isolates and was associated with bacteremia and prolonged hospitalization.
Conclusions:
Staphylococcus aureus is an important cause of morbidity among children with CHD. Infective endocarditis was common with S aureus bacteremia in this population; in addition, prolonged bacteremia, thrombocytopenia, and CRP >10 mg/dL may serve as diagnostic adjuncts for IE. qacA/B-positive isolates are associated with adverse clinical outcomes.
Related Concept Videos
Staphylococcal Skin Infections
Endocarditis I: Introduction
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease I: Introduction
Mechanism of Antibiotic Resistance in MRSA
Mitral Stenosis I: Introduction

